► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Reckitt Benckiser has made a $1.4bn offer for Schiff, the US vitamins and nutritional supplements company. This trumps an earlier offer by Bayer, setting up a potential bidding war. Lex's Vincent Boland and Oliver Ralph discuss why Reckitt is paying so much and whether Bayer can respond.
Related Articles:
http://www.ft.com/intl/cms/s/3/2217b1a4-2ffd-11e2-ae7d-00144feabdc0.html
http://www.ft.com/intl/cms/s/0/8c0bb46c-2f70-11e2-8e4b-00144feabdc0.html
For more video content from the Financial Times visit http://www.FT.com/video
